UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Variable and evolving degrees of CFTR dysfunction: Implications for diagnosis and clinical management

Paediatric respiratory reviews, 2023-09, Vol.47, p.16-18

2023

Volltextzugriff (PDF)

The potential of bacteriophage therapy in the treatment of paediatric respiratory infections

Paediatric respiratory reviews, 2022-12, Vol.44, p.70-77

2022

Volltextzugriff (PDF)

Nissen's Fundoplication Is Safe and Prevents Decrease in Forced Expiratory Volume in One Second (FEV1 ) in Paediatric Lung Transplant Patients

The Journal of heart and lung transplantation, 2017-04, Vol.36 (4), p.S276-S276

2017

Volltextzugriff (PDF)

48 Characteristics of initial sleep study in infants with Prader Willi Syndrome

BMJ open respiratory research, 2021-11, Vol.8 (Suppl 1), p.A23-A23

2021

Volltextzugriff (PDF)

503: Detecting and treating Aspergillus fumigatus infection—Can sputum galactomannan help?

Journal of cystic fibrosis, 2021-11, Vol.20, p.S237-S238

2021

Volltextzugriff (PDF)

140 Towards the clinical application of anti-pseudomonal bacteriophages: Activity is retained following nebulisation with a range of commercially available nebuliser systems

Journal of cystic fibrosis, 2015-06, Vol.14, p.S93-S93

2015

Volltextzugriff (PDF)

WS16.5 Selective ion-flow mass spectrometry (SIFT-MS) analysis of exhaled breath as a non-invasive determinant of Pseudomonas aeruginosa infection in CF patients

Journal of cystic fibrosis, 2014-06, Vol.13, p.S34-S34

2014

Volltextzugriff (PDF)

EPS4.01 Using a modified glucose challenge test (GCT) as a screening tool for cystic fibrosis diabetes

Journal of cystic fibrosis, 2023-06, Vol.22, p.S46-S46

2023

Volltextzugriff (PDF)

WS11.6 Interpretation of nasal potential difference (nPD) measurements in difficult cases of possible cystic fibrosis and the role of published equations

Journal of cystic fibrosis, 2014-06, Vol.13, p.S24-S24

2014

Volltextzugriff (PDF)

P200 Galactomannan Gold? Unveiling Aspergillus infections in cystic fibrosis children

Journal of cystic fibrosis, 2024-06, Vol.23, p.S130-S131

2024

Volltextzugriff (PDF)

96 Is sputum galactomannan a feasible screening test for Aspergillus infection in children with cystic fibrosis?

Journal of cystic fibrosis, 2023-10, Vol.22, p.S49-S50

2023

Volltextzugriff (PDF)

WS17.4 Anti-pseudomonal bacteriophage cocktail reduces inflammatory responses in the murine lung

Journal of cystic fibrosis, 2013-06, Vol.12, p.S34-S34

2013

Volltextzugriff (PDF)

ePS6.06 Variability in response of chronic Pseudomonas aeruginosa isolates to a lytic bacteriophage mix and standard antibiotics over a year

Journal of cystic fibrosis, 2019-06, Vol.18, p.S54-S55

2019

Volltextzugriff (PDF)

S55 Towards the Clinical Application of Anti-pseudomonal Bacteriophage: Activity is Retained Following Nebulisation with a Range of Commercially Available Nebuliser Systems

Thorax, 2015-12, Vol.70 (Suppl 3), p.A34-A34

2015

Volltextzugriff (PDF)

WS17.5 Nasal potential difference measurement increases the diagnostic yield in patients with equivocal first-line cystic fibrosis investigations: the experience of a large national CFTR diagnostic service

Journal of cystic fibrosis, 2018-06, Vol.17, p.S32-S32

2018

Volltextzugriff (PDF)

S9SIFT-MS analysis as a non-invasive determinant of pseudomonas aeruginosa infection in patients with cystic fibrosis

Thorax, 2013-12, Vol.68 (Suppl 3), p.A8-A8

2013

Volltextzugriff (PDF)

S112 Variability in susceptibility to antibiotics and bacteriophages between individual colonies of Pseudomonas aeruginosa from cystic fibrosis sputum samples: implications for future clinical trial design

Thorax, 2015-12, Vol.70 (Suppl 3), p.A64-A65

2015

Volltextzugriff (PDF)

S9 SIFT-MS analysis as a non-invasive determinant of pseudomonas aeruginosa infection in patients with cystic fibrosis

Thorax, 2013-12, Vol.68 (Suppl 3), p.A8-A8

2013

Volltextzugriff (PDF)

S123 The Role of Nasal Potential Difference Testing in Difficult Cases of Possible Cystic Fibrosis

Thorax, 2012-12, Vol.67 (Suppl 2), p.A59-A59

2012

Volltextzugriff (PDF)

S103Anti-Pseudomonal Bacteriophage Cocktail Reduces Inflammatory Responses in the Murine Lung

Thorax, 2012-12, Vol.67 (Suppl 2), p.A50-A51

2012

Volltextzugriff (PDF)

S103 Anti-Pseudomonal Bacteriophage Cocktail Reduces Inflammatory Responses in the Murine Lung

Thorax, 2012-12, Vol.67 (Suppl 2), p.A50-A51

2012

Volltextzugriff (PDF)

Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches

Expert review of respiratory medicine, 2016-06, Vol.10 (6), p.685-697

2016

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

Pulmonary/respiratory
(4)
Life Sciences & Biomedicine
(3)
Pediatrics
(3)
Pseudomonas Aeruginosa
(3)
Respiratory System
(3)
Science & Technology
(3)
Anti-Bacterial Agents - Therapeutic Use
(2)
Cystic Fibrosis
(2)
Humans
(2)
Abstracts
(1)
Airway
(1)
Antibiotic
(1)
Antibiotic Resistance
(1)
Babies
(1)
Bacteria
(1)
Bacterial Infections - Therapy
(1)
Bacteriophage
(1)
Bacteriophages
(1)
Biofilm
(1)
Child
(1)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Cystic Fibrosis
(10)
Thorax
(7)
Paediatric Respiratory Reviews
(2)
Abstracts
(1)
Bmj Open Respiratory Research
(1)
Expert Review Of Respiratory Medicine
(1)
The Journal Of Heart And Lung Transplantation
(1)

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Variable and evolving degrees of CFTR dysfunction: Implications for diagnosis and clinical management

The potential of bacteriophage therapy in the treatment of paediatric respiratory infections

Nissen's Fundoplication Is Safe and Prevents Decrease in Forced Expiratory Volume in One Second (FEV1 ) in Paediatric Lung Transplant Patients

48 Characteristics of initial sleep study in infants with Prader Willi Syndrome

503: Detecting and treating Aspergillus fumigatus infection—Can sputum galactomannan help?

140 Towards the clinical application of anti-pseudomonal bacteriophages: Activity is retained following nebulisation with a range of commercially available nebuliser systems

WS16.5 Selective ion-flow mass spectrometry (SIFT-MS) analysis of exhaled breath as a non-invasive determinant of Pseudomonas aeruginosa infection in CF patients

EPS4.01 Using a modified glucose challenge test (GCT) as a screening tool for cystic fibrosis diabetes

WS11.6 Interpretation of nasal potential difference (nPD) measurements in difficult cases of possible cystic fibrosis and the role of published equations

P200 Galactomannan Gold? Unveiling Aspergillus infections in cystic fibrosis children

96 Is sputum galactomannan a feasible screening test for Aspergillus infection in children with cystic fibrosis?

WS17.4 Anti-pseudomonal bacteriophage cocktail reduces inflammatory responses in the murine lung

ePS6.06 Variability in response of chronic Pseudomonas aeruginosa isolates to a lytic bacteriophage mix and standard antibiotics over a year

S55 Towards the Clinical Application of Anti-pseudomonal Bacteriophage: Activity is Retained Following Nebulisation with a Range of Commercially Available Nebuliser Systems

WS17.5 Nasal potential difference measurement increases the diagnostic yield in patients with equivocal first-line cystic fibrosis investigations: the experience of a large national CFTR diagnostic service

S9SIFT-MS analysis as a non-invasive determinant of pseudomonas aeruginosa infection in patients with cystic fibrosis

S112 Variability in susceptibility to antibiotics and bacteriophages between individual colonies of Pseudomonas aeruginosa from cystic fibrosis sputum samples: implications for future clinical trial design

S9 SIFT-MS analysis as a non-invasive determinant of pseudomonas aeruginosa infection in patients with cystic fibrosis

S123 The Role of Nasal Potential Difference Testing in Difficult Cases of Possible Cystic Fibrosis

S103Anti-Pseudomonal Bacteriophage Cocktail Reduces Inflammatory Responses in the Murine Lung

S103 Anti-Pseudomonal Bacteriophage Cocktail Reduces Inflammatory Responses in the Murine Lung

Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches

Suchergebnisse filtern